Illinois Governor JB Pritzker announced he used GLP-1 medication to lose 80 pounds. He shared the details during an interview on “CBS Mornings.”
Pritzker began the weight-loss regimen in 2024. He has since become a prominent figure in discussions about the drug class.
GLP-1s, including Ozempic and Wegovy, mimic a gut hormone to suppress appetite. They were originally developed to treat type 2 diabetes.
The governor is widely viewed as a potential contender in the 2028 presidential race. His disclosure adds a personal dimension to his public profile.
Weight-loss drugs have surged in popularity across the United States. Demand has sometimes outpaced supply, prompting ongoing production adjustments.
Pritzker’s comments reflect a growing openness among public figures. Many now discuss their use of these treatments without stigma.
Medical experts note that GLP-1s carry side effects and require prescriptions. They are not intended as a quick fix for weight loss.
The disclosure may influence how voters perceive the governor’s health and discipline. It also ties him to a major cultural and medical trend.
Pritzker did not specify which GLP-1 medication he used. He also did not detail his diet or exercise habits during the period.
His announcement follows similar revelations from other politicians and celebrities. The trend underscores the shifting norms around body image and aging.
